Safety and Efficacy of XP200 Radiofrequency Treatment of Wrinkles

Sponsor
BTL Industries Ltd. (Industry)
Overall Status
Completed
CT.gov ID
NCT01795417
Collaborator
(none)
50
1
7

Study Details

Study Description

Brief Summary

To evaluate the wrinkle-reducing effects of 3.25-MHz radiofrequency (RF) energy delivered in 4 weekly applications to human periorbital skin area by grating pre- and 90-days post treatment photographs on the Fitzpatrick Wrinkle Severity Scale (FWSS) by three blinded evaluators.

Condition or Disease Intervention/Treatment Phase
  • Device: RF XP200
  • Device: XP200 RF device
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
50 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Safety and Efficacy of Non-invasive Dermatologic Procedure With XP200 Radiofrequency for the Primary Treatment of Wrinkles and Rhytids
Study Start Date :
Aug 1, 2012
Actual Primary Completion Date :
Dec 1, 2012
Actual Study Completion Date :
Mar 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: XP200 device RF treatments

Every subject in the study will undergo 4 treatments and will be followed up for 6 months with photoraphic 3 evaluations: before treatment, 3 and 6 months follow-up. Photographs will be scored on a Fitzpatrick scale by 3 blinded evaluators.

Device: RF XP200
Four weekly non-invasive periorbital wrinkles treatment with RF XP200 device

Device: XP200 RF device
4 RF treatments of periorbital region on one side of the face

Outcome Measures

Primary Outcome Measures

  1. Improvement in wrinkles appearance [3 months]

    One point or greater improvement in periorbital wrinkle score on a Fitzpatrick scale 3 months after last treatment as determined by at least 2 out of 3 blinded photographs evaluators

Eligibility Criteria

Criteria

Ages Eligible for Study:
35 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 35-60 years old

  • periorbital wrinkles

Exclusion Criteria:

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • BTL Industries Ltd.

Investigators

  • Study Director: Georgi Petkov, BTL Industries Ltd.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
BTL Industries Ltd.
ClinicalTrials.gov Identifier:
NCT01795417
Other Study ID Numbers:
  • XP200 3.25 MHZ RF
First Posted:
Feb 20, 2013
Last Update Posted:
Aug 7, 2013
Last Verified:
Aug 1, 2013
Keywords provided by BTL Industries Ltd.

Study Results

No Results Posted as of Aug 7, 2013